Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications

Bioconjugate Chemistry

Volumn 19, Issue 12, 2008, Pages 2346-2356

  Walther, Cornelia ^a   Meyer, Karolin ^a   Rennert, Robert ^a   Neundorf, Ines ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Pharm Psychol   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CALCITONIN; CALCITONIN DERIVATIVE; CHLOROQUINE; NANOPARTICLE; OLIGONUCLEOTIDE; PEPTIDE; QUANTUM DOT; RNA; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CELL STRAIN HEK293; CELL VIABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; HELA CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; MOLECULAR WEIGHT;

EID: 58149088420     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800172q     Document Type: Article

References (44)

1. Jaiswal, J. K., Mattoussi, H., Mauro, J. M., and Simon, S. M. (2003) Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47-51.
2. Smith, A. M., and Nie, S. (2004) Chemical analysis and cellular imaging with quantum dots. Analyst 129, 672-677.
3. Watson, A., Wu, X., and Bruchez, M. (2003) Lighting up cells with quantum dots. Biotechniques 34, 296300, 302-303.
4. Mae, M., and Langel, U. (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 6, 509-514.
5. Snyder, E. L., and Dowdy, S. F. (2005) Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin. Drug Delivery 2, 43-51.
6. Delehanty, J. B., Medintz, I. L., Pons, T., Brunel, F. M., Dawson, P. E., and Mattoussi, H. (2006) Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjugate Chem. 17, 920-927.
7. Lagerholm, B. C., Wang, M., Ernst, L. A., Ly, D. H., Liu, H., Bruchez, M. P., and Waggoner, A. S. (2004) Multicolor coding of cells with cationic peptide coated quantum dots. Nano Lett. 4, 2019-2022.
8. Bendifallah, N., Rasmussen, F. W., Zachar, V., Ebbesen, P., Nielsen, P. E., and Koppelhus, U. (2006) Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjugate Chem. 17, 750-758.
9. Pooga, M., Kut, C., Kihlmark, M., Hallbrink, M., Fernaeus, S., Raid, R., Land, T., Hallberg, E., Bartfai, T., and Langel, U. (2001) Cellular translocation of proteins by transportan. Faseb J. 15, 1451-1453.
10. Turner, J. J., Arzumanov, A. A., and Gait, M. J. (2005) Synthesis, cellular uptake and HIV-1 Tat-dependent transactivation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res. 33, 27-42.
11. Akerman, M. E., Chan, W. C., Laakkonen, P., Bhatia, S. N., and Ruoslahti, E. (2002) Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U.S.A. 99, 12617-12621.
12. Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Scadden, D. T., and Weissleder, R. (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.
13. Pontiroli, A. E., Alberetto, M., and Pozza, G. (1985) Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br. Med. J. (Clin. Res. Ed.) 290, 1390-1391.
14. Stroop, S. D., Nakamuta, H., Kuestner, R. E., Moore, E. E., and Epand, R. M. (1996) Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. Endocrinology 137, 4752-4756.
15. Neundorf, I., and Beck-Sickinger, A. G. (2005) Calcitonin-derived carrier peptides. Curr. Pharm. Des. 11, 3661-3669, Calcitonin-derived carrier peptides.
16. Krauss, U., Kratz, F., and Beck-Sickinger, A. G. (2003) Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. J. Mol. Recognit. 16, 280-287.
17. Machova, Z., Muhle, C., Krauss, U., Trehin, R., Koch, A., Merkle, H. P., and Beck-Sickinger, A. G. (2002) Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. ChemBioChem 3, 672-677.
18. Rennert, R., Wespe, C., Beck-Sickinger, A. G., and Neundorf, I. (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Biochim. Biophys. Acta 1758, 347-354.
19. Rennert, R., Neundorf, I., and Beck-Sickinger, A. G. (2008) Calcitonin-derived peptide carriers: mechanisms and application. Adv. Drug Delivery Rev. 60, 485-498.
20. Krauss, U., Muller, M., Stahl, M., and Beck-Sickinger, A. G. (2004) In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. Bioorg. Med. Chem. Lett. 14, 51-54.
21. Rennert, R., Neundorf, I., Jahnke, H. G., Suchowerskyj, P., Dournaud, P., Robitzki, A., and Beck-Sickinger, A. G. (2008) Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells. ChemMedChem 3, 241-253.
22. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., Rennert, R., Beck-Sickinger, A. G., and Merkle, H. P. (2005) Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44, 72-81.
23. Ruan, G., Agrawal, A., Marcus, A. I., and Nie, S. (2007) Imaging and tracking of Tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J. Am. Chem. Soc. 129, 14759-14766.
24. Nichols, B. J., Kenworthy, A. K., Polishchuk, R. S., Lodge, R., Roberts, T. H., Hirschberg, K., Phair, R. D., and Lippincott-Schwartz, J. (2001) Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153, 529-541.
25. Puri, V., Watanabe, R., Singh, R. D., Dominguez, M., Brown, J. C., Wheatley, C. L., Marks, D. L., and Pagano, R. E. (2001) Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J. Cell Biol. 154, 535-547.
26. Thorstensen, K., and Romslo, I. (1988) Uptake of iron from transferrin by isolated rat hepatocytes. A redox-mediated plasma membrane process? J. Biol. Chem. 263, 8844-8850.
27. Shpetner, H., Joly, M., Hartley, D., and Corvera, S. (1996) Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132, 595-605.
28. Swanson, J. A., and Watts, C. (1995) Macropinocytosis. Trends Cell Biol. 5, 424-428.
29. Le, P. U., and Nabi, I. R. (2003) Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116, 1059-1071.
30. Ikonen, E. (2001) Roles of lipid rafts in membrane transport. Curr. Opin. Cell Biol. 13, 470-477.
31. Cheng, J., Zeidan, R., Mishra, S., Liu, A., Pun, S. H., Kulkarni, R. P., Jensen, G. S., Bellocq, N. C., and Davis, M. E. (2006) Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery. J. Med. Chem. 49, 6522-6531.
32. Zhou, M., Nakatani, E., Gronenberg, L. S., Tokimoto, T., Wirth, M. J., Hruby, V. J., Roberts, A., Lynch, R. M., and Ghosh, I. (2007) Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules. Bioconjugate Chem. 18, 323-332.
33. Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., and Bruchez, M. P. (2003) Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41-46.
34. Duan, H., and Nie, S. (2007) Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J. Am. Chem. Soc. 129, 3333-3338.
35. Derfus, A. M., Chen, A. A., Min, D. H., Ruoslahti, E., and Bhatia, S. N. (2007) Targeted quantum dot conjugates for siRNA delivery. Bioconjugate Chem. 18, 1391-1396.
36. Rennert, R., Neundorf, I., Beck-Sickinger, A. G. (2007) Synthesis and application of peptides as drug carriers. Nucleic Acid and Peptide Aptamers edition of the Methods in Molecular Biology series, Humana Press Inc., Totowa, USA, accepted.
37. Kaplan, I. M., Wadia, J. S., and Dowdy, S. F. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Controlled Release 102, 247-253.
38. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866.
39. Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T., and Jones, A. T. (2007) Arginine-rich peptides and their internalization mechanisms. Biochem. Soc. Trans. 35, 784-787.
40. Singh, R. D., Puri, V., Valiyaveettil, J. T., Marks, D. L., Bittman, R., and Pagano, R. E. (2003) Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell 14, 3254-3265.
41. Torgersen, M. L., Skretting, G., van Deurs, B., and Sandvig, K. (2001) Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 114, 3737-3747.
42. Kirkham, M., Fujita, A., Chadda, R., Nixon, S. J., Kurzchalia, T. V., Sharma, D. K., Pagano, R. E., Hancock, J. F., Mayor, S., and Parton, R. G. (2005) Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168, 465-476.
43. Kirkham, M., and Parton, R. G. (2005) Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 1745, 273-286.
44. Harush-Frenkel, O., Debotton, N., Benita, S., and Altschuler, Y. (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun. 353, 26-32.